top of page

NEOPHARMA TECHNOLOGIES, LTD.
Investor Relations

NEO IR WEB Back Artboard 1.png

A presentation at the office

PRESS RELEAESES:

Investor Calendar

Webcasts & Presentations

Quarterly Results

Convert stock Announcement.png

March 10, 2025 - Neopharma Technologies, Ltd. Announces Proposed Offering of Mandatory Convertible Preferred Stock.

View Press Release

NEO Announcement-AUSCHAIN.png

February 27, 2025 - Neopharma Technologies Announces Strategic Partnership with AusChain to Assist with the Scaling and Global Rollout of NEOVAULT®.

View Press Release

Screenshot 2025-03-11 150351.png

February 5, 2025 - Neopharma Technologies and Impairment Science Strengthen Partnership to Revolutionize Drug and Impairment Testing.

View Press Release

Screenshot 2025-03-11 150635.png

December 20, 2024 - Neopharma Technologies Announces Strategic Partnership to Distribute 5 Million Drug Tests with NEOVAULT® Technology.

View Press Release

Screenshot 2025-03-12 110529.png

Nina M. French Announced as New CEO to join Neopharma Technologies Limited

View Press Release

Screenshot 2025-03-12 111759.png

Neopharma Technologies recognised as the Top 100 Healthcare Technology company in 2021. Leading the way in Drugs-of-Abuse Testing.

View Press Release

Dividend Information

Tax Disclosures

Committee Composition

bottom of page